Annual CFI
$792.00 M
-$176.00 M-18.18%
December 31, 2024
Summary
- As of February 25, 2025, TEVA annual cash flow from investing activities is $792.00 million, with the most recent change of -$176.00 million (-18.18%) on December 31, 2024.
- During the last 3 years, TEVA annual CFI has fallen by -$731.00 million (-48.00%).
- TEVA annual CFI is now -77.02% below its all-time high of $3.45 billion, reached on December 31, 2017.
Performance
TEVA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$202.00 M
-$66.00 M-24.63%
December 31, 2024
Summary
- As of February 25, 2025, TEVA quarterly cash flow from investing activities is $202.00 million, with the most recent change of -$66.00 million (-24.63%) on December 31, 2024.
- Over the past year, TEVA quarterly CFI has stayed the same.
- TEVA quarterly CFI is now -89.44% below its all-time high of $1.91 billion, reached on December 31, 2017.
Performance
TEVA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$792.00 M
-$99.00 M-11.11%
December 31, 2024
Summary
- As of February 25, 2025, TEVA TTM cash flow from investing activities is $792.00 million, with the most recent change of -$99.00 million (-11.11%) on December 31, 2024.
- Over the past year, TEVA TTM CFI has stayed the same.
- TEVA TTM CFI is now -78.62% below its all-time high of $3.70 billion, reached on September 30, 2018.
Performance
TEVA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
TEVA Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.2% | 0.0% | 0.0% |
| 3 y3 years | -48.0% | 0.0% | 0.0% |
| 5 y5 years | -41.5% | 0.0% | 0.0% |
TEVA Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -48.0% | +20.7% | -33.1% | +40.3% | -48.0% | +20.7% |
| 5 y | 5-year | -48.0% | +20.7% | -60.2% | +43.3% | -48.0% | +20.7% |
| alltime | all time | -77.0% | +102.3% | -89.4% | +100.6% | -78.6% | +102.3% |
Teva Pharmaceutical Industries Limited Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $792.00 M(-18.2%) | $202.00 M(-24.6%) | $792.00 M(-11.1%) |
| Sep 2024 | - | $268.00 M(+50.6%) | $891.00 M(+10.4%) |
| Jun 2024 | - | $178.00 M(+23.6%) | $807.00 M(-13.3%) |
| Mar 2024 | - | $144.00 M(-52.2%) | $931.00 M(-3.8%) |
| Dec 2023 | $968.00 M(+47.6%) | $301.00 M(+63.6%) | $968.00 M(+15.9%) |
| Sep 2023 | - | $184.00 M(-39.1%) | $835.00 M(+4.6%) |
| Jun 2023 | - | $302.00 M(+66.9%) | $798.00 M(+18.0%) |
| Mar 2023 | - | $181.00 M(+7.7%) | $676.00 M(+3.0%) |
| Dec 2022 | $656.00 M(-56.9%) | $168.00 M(+14.3%) | $656.00 M(-10.6%) |
| Sep 2022 | - | $147.00 M(-18.3%) | $734.00 M(-16.1%) |
| Jun 2022 | - | $180.00 M(+11.8%) | $875.00 M(-25.6%) |
| Mar 2022 | - | $161.00 M(-34.6%) | $1.18 B(-22.8%) |
| Dec 2021 | $1.52 B(+76.5%) | $246.00 M(-14.6%) | $1.52 B(+7.4%) |
| Sep 2021 | - | $288.00 M(-40.1%) | $1.42 B(+10.2%) |
| Jun 2021 | - | $481.00 M(-5.3%) | $1.29 B(+15.0%) |
| Mar 2021 | - | $508.00 M(+260.3%) | $1.12 B(+29.7%) |
| Dec 2020 | $863.00 M(-36.3%) | $141.00 M(-10.2%) | $863.00 M(-25.1%) |
| Sep 2020 | - | $157.00 M(-49.8%) | $1.15 B(-5.5%) |
| Jun 2020 | - | $313.00 M(+24.2%) | $1.22 B(-8.7%) |
| Mar 2020 | - | $252.00 M(-41.4%) | $1.33 B(-1.5%) |
| Dec 2019 | $1.35 B(-27.4%) | $430.00 M(+92.0%) | $1.35 B(+35.6%) |
| Sep 2019 | - | $224.00 M(-47.8%) | $999.00 M(-11.0%) |
| Jun 2019 | - | $429.00 M(+57.7%) | $1.12 B(+2.1%) |
| Mar 2019 | - | $272.00 M(+267.6%) | $1.10 B(-41.1%) |
| Dec 2018 | $1.87 B(-45.9%) | $74.00 M(-78.7%) | $1.87 B(-49.6%) |
| Sep 2018 | - | $347.00 M(-14.5%) | $3.70 B(+7.0%) |
| Jun 2018 | - | $406.00 M(-60.9%) | $3.46 B(+16.6%) |
| Mar 2018 | - | $1.04 B(-45.7%) | $2.97 B(-13.8%) |
| Dec 2017 | $3.45 B(-110.0%) | $1.91 B(+1738.5%) | $3.45 B(+66.3%) |
| Sep 2017 | - | $104.00 M(-220.9%) | $2.07 B(-106.8%) |
| Jun 2017 | - | -$86.00 M(-105.7%) | -$30.33 B(-0.5%) |
| Mar 2017 | - | $1.52 B(+181.8%) | -$30.47 B(-11.4%) |
| Dec 2016 | -$34.41 B(+518.2%) | $538.00 M(-101.7%) | -$34.41 B(-2.4%) |
| Sep 2016 | - | -$32.30 B(>+9900.0%) | -$35.24 B(+1047.4%) |
| Jun 2016 | - | -$225.00 M(-90.7%) | -$3.07 B(-60.4%) |
| Mar 2016 | - | -$2.42 B(+724.9%) | -$7.76 B(+39.5%) |
| Dec 2015 | -$5.57 B(+283.8%) | -$293.00 M(+115.4%) | -$5.57 B(-1.0%) |
| Sep 2015 | - | -$136.00 M(-97.2%) | -$5.62 B(-6.5%) |
| Jun 2015 | - | -$4.92 B(+2145.2%) | -$6.01 B(+369.2%) |
| Mar 2015 | - | -$219.00 M(-36.9%) | -$1.28 B(-11.7%) |
| Dec 2014 | -$1.45 B(+26.4%) | -$347.00 M(-34.3%) | -$1.45 B(+2.2%) |
| Sep 2014 | - | -$528.00 M(+182.4%) | -$1.42 B(+19.2%) |
| Jun 2014 | - | -$187.00 M(-51.8%) | -$1.19 B(-6.2%) |
| Mar 2014 | - | -$388.00 M(+22.8%) | -$1.27 B(+10.6%) |
| Dec 2013 | -$1.15 B(+1.1%) | -$316.00 M(+5.7%) | -$1.15 B(-7.5%) |
| Sep 2013 | - | -$299.00 M(+12.4%) | -$1.24 B(+4.2%) |
| Jun 2013 | - | -$266.00 M(0.0%) | -$1.19 B(-1.3%) |
| Mar 2013 | - | -$266.00 M(-35.0%) | -$1.21 B(+6.3%) |
| Dec 2012 | -$1.13 B(-85.1%) | -$409.00 M(+64.3%) | -$1.13 B(-81.8%) |
| Sep 2012 | - | -$249.00 M(-11.7%) | -$6.22 B(-13.2%) |
| Jun 2012 | - | -$282.00 M(+45.4%) | -$7.16 B(+0.6%) |
| Mar 2012 | - | -$194.00 M(-96.5%) | -$7.12 B(-6.3%) |
| Dec 2011 | -$7.60 B | -$5.49 B(+359.9%) | -$7.60 B(+226.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2011 | - | -$1.19 B(+397.5%) | -$2.33 B(-62.7%) |
| Jun 2011 | - | -$240.00 M(-64.5%) | -$6.23 B(+7.4%) |
| Mar 2011 | - | -$676.00 M(+213.0%) | -$5.80 B(+6.4%) |
| Dec 2010 | -$5.46 B(+495.5%) | -$216.00 M(-95.8%) | -$5.46 B(-0.9%) |
| Sep 2010 | - | -$5.10 B(-2798.4%) | -$5.50 B(+645.5%) |
| Jun 2010 | - | $189.00 M(-157.6%) | -$738.00 M(-33.0%) |
| Mar 2010 | - | -$328.00 M(+24.7%) | -$1.10 B(+20.3%) |
| Dec 2009 | -$916.00 M(-77.9%) | -$263.00 M(-21.7%) | -$916.00 M(-79.7%) |
| Sep 2009 | - | -$336.00 M(+92.0%) | -$4.51 B(+4.2%) |
| Jun 2009 | - | -$175.00 M(+23.2%) | -$4.33 B(-1.5%) |
| Mar 2009 | - | -$142.00 M(-96.3%) | -$4.39 B(+6.2%) |
| Dec 2008 | -$4.14 B(+205.8%) | -$3.86 B(+2403.9%) | -$4.14 B(+481.9%) |
| Sep 2008 | - | -$154.00 M(-36.4%) | -$711.00 M(-9.0%) |
| Jun 2008 | - | -$242.00 M(-310.4%) | -$781.00 M(+44.4%) |
| Mar 2008 | - | $115.00 M(-126.7%) | -$541.00 M(-60.0%) |
| Dec 2007 | -$1.35 B(-66.7%) | -$430.00 M(+92.0%) | -$1.35 B(+52.1%) |
| Sep 2007 | - | -$224.00 M(>+9900.0%) | -$889.30 M(-28.3%) |
| Jun 2007 | - | -$2.00 M(-99.7%) | -$1.24 B(-21.0%) |
| Mar 2007 | - | -$697.00 M(-2168.2%) | -$1.57 B(-61.3%) |
| Dec 2006 | -$4.06 B(+654.3%) | $33.70 M(-105.9%) | -$4.06 B(-1.7%) |
| Sep 2006 | - | -$575.20 M(+73.0%) | -$4.13 B(+5.5%) |
| Jun 2006 | - | -$332.50 M(-89.6%) | -$3.91 B(+7.0%) |
| Mar 2006 | - | -$3.18 B(+8623.3%) | -$3.66 B(+579.9%) |
| Dec 2005 | -$538.00 M(-77.5%) | -$36.50 M(-89.9%) | -$538.00 M(-42.6%) |
| Sep 2005 | - | -$361.20 M(+375.3%) | -$936.70 M(+41.2%) |
| Jun 2005 | - | -$76.00 M(+18.2%) | -$663.30 M(-17.3%) |
| Mar 2005 | - | -$64.30 M(-85.2%) | -$801.70 M(-66.5%) |
| Dec 2004 | -$2.39 B(+450.0%) | -$435.20 M(+395.7%) | -$2.39 B(+23.6%) |
| Sep 2004 | - | -$87.80 M(-59.0%) | -$1.94 B(-5.9%) |
| Jun 2004 | - | -$214.40 M(-87.1%) | -$2.06 B(+3.1%) |
| Mar 2004 | - | -$1.66 B(-7591.4%) | -$1.99 B(+358.3%) |
| Dec 2003 | -$435.10 M(-34.6%) | $22.10 M(-110.6%) | -$435.10 M(-11.0%) |
| Sep 2003 | - | -$208.40 M(+36.8%) | -$488.80 M(-12.3%) |
| Jun 2003 | - | -$152.30 M(+57.8%) | -$557.50 M(-6.0%) |
| Mar 2003 | - | -$96.50 M(+205.4%) | -$593.20 M(-10.8%) |
| Dec 2002 | -$664.90 M(+248.7%) | -$31.60 M(-88.6%) | -$664.90 M(-5.4%) |
| Sep 2002 | - | -$277.10 M(+47.4%) | -$702.55 M(+51.1%) |
| Jun 2002 | - | -$188.00 M(+11.8%) | -$464.92 M(+41.1%) |
| Mar 2002 | - | -$168.20 M(+142.9%) | -$329.38 M(+72.8%) |
| Dec 2001 | -$190.65 M(+126.1%) | -$69.25 M(+75.5%) | -$190.65 M(+57.0%) |
| Sep 2001 | - | -$39.47 M(-24.8%) | -$121.40 M(+48.2%) |
| Jun 2001 | - | -$52.46 M(+78.0%) | -$81.93 M(+178.0%) |
| Mar 2001 | - | -$29.47 M | -$29.47 M |
| Dec 2000 | -$84.31 M(-69.0%) | - | - |
| Dec 1999 | -$271.87 M(+104.2%) | - | - |
| Dec 1998 | -$133.11 M(+104.2%) | - | - |
| Dec 1997 | -$65.20 M(-48.7%) | - | - |
| Dec 1996 | -$127.00 M(-0.2%) | - | - |
| Dec 1995 | -$127.30 M(+48.2%) | - | - |
| Dec 1994 | -$85.90 M(+57.3%) | - | - |
| Dec 1993 | -$54.60 M(+22.4%) | - | - |
| Dec 1992 | -$44.60 M(-7.7%) | - | - |
| Dec 1991 | -$48.30 M | - | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual cash flow from investing activities?
- What is the all time high annual CFI for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual CFI year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly CFI year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM cash flow from investing activities?
- What is the all time high TTM CFI for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM CFI year-on-year change?
What is Teva Pharmaceutical Industries Limited annual cash flow from investing activities?
The current annual CFI of TEVA is $792.00 M
What is the all time high annual CFI for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual cash flow from investing activities is $3.45 B
What is Teva Pharmaceutical Industries Limited annual CFI year-on-year change?
Over the past year, TEVA annual cash flow from investing activities has changed by -$176.00 M (-18.18%)
What is Teva Pharmaceutical Industries Limited quarterly cash flow from investing activities?
The current quarterly CFI of TEVA is $202.00 M
What is the all time high quarterly CFI for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly cash flow from investing activities is $1.91 B
What is Teva Pharmaceutical Industries Limited quarterly CFI year-on-year change?
Over the past year, TEVA quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Teva Pharmaceutical Industries Limited TTM cash flow from investing activities?
The current TTM CFI of TEVA is $792.00 M
What is the all time high TTM CFI for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM cash flow from investing activities is $3.70 B
What is Teva Pharmaceutical Industries Limited TTM CFI year-on-year change?
Over the past year, TEVA TTM cash flow from investing activities has changed by $0.00 (0.00%)